[Skip to Content]
[Skip to Content Landing]
February 1, 1947


JAMA. 1947;133(5):344. doi:10.1001/jama.1947.02880050064022

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


To the Editor:—  I should like to call attention to an article in the Dec. 28, 1946 issue of The Journal, page 1070, entitled "Guillain-Barré Syndrome Treated with Neostigmine."Comparatively few readers would know what the Guillain-Barré syndrome was, although most of us would know virus encephalomyelitis. Many of us would not bother reading about the Guillain-Barré syndrome since it would be completely foreign to us, while we would be highly interested to know about neostigmine treatment of such a common condition as virus encephalomyelitis. Thus perhaps valuable information would be missed because of personal name reference.How much more interesting would it be if it read "Virus Encephalomyelitis Treated with Neostigmine." If it is really necessary to cater to the name of the man or men who first described a certain disease for reasons of stimulating people's interest or for reasons of good will, their name might be put

First Page Preview View Large
First page PDF preview
First page PDF preview